Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant

Tanja Fehm, Arthur I Sagalowsky, Edward Clifford, Peter Beitsch, Hossein Saboorian, David Euhus, Songdong Meng, Larry Morrison, Thomas Tucker, Nancy Lane, B. Michael Ghadimi, Kerstin Heselmeyer-Haddad, Thomas Ried, Chandra Rao, Jonathan Uhr

Research output: Contribution to journalArticle

256 Citations (Scopus)

Abstract

Purpose: Numerous studies of circulating epithelial cells (CECs) have been described in cancer patients, and genetic abnormalities have been well documented. However, with one exception in colorectal cancer, there has been no report of matching the genetic abnormalities in the CECs with the primary tumor. The purpose of this investigation was to determine (a) whether CECs in patients including those with early tumors are aneusomic and (b) whether their aneusomic patterns match those from the primary tumor, indicating common clonality. Experimental Design: Thirty-one cancer patients had CECs identified by immunofluorescence staining using a monoclonal anti-cytokeratin antibody. Their CECs were analyzed by enumerator DNA probes for chromosomes 1, 3, 4, 7, 8, 11, or 17 by dual or tricolor fluorescence in situ hybridization. Touch preparations of the primary tumor tissue were available from 17 of 31 patients and hybridized with the same set of probes used to genotype the CECs. Results: The number of CECs from each patient ranged from 1-92 cells/cytospin. CECs showed abnormal copy numbers for at least one of the probes in 25 of 31 patients. Touch preparations from the primary tumors of 13 patients with aneusomic CECs were available. The pattern of aneusomy matched a clone in the primary tumor in 10 patients. Conclusions: We conclude that the vast majority of CECs in breast, kidney, prostate, and colon cancer patients are aneusomic and derived from the primary tumor.

Original languageEnglish (US)
Pages (from-to)2073-2084
Number of pages12
JournalClinical Cancer Research
Volume8
Issue number7
StatePublished - 2002

Fingerprint

Cytogenetics
Epithelial Cells
Carcinoma
Neoplasms
Touch
Chromosomes, Human, Pair 3
Kidney Neoplasms
Chromosomes, Human, Pair 1
DNA Probes
Keratins
Fluorescence In Situ Hybridization
Colonic Neoplasms
Fluorescent Antibody Technique
Anti-Idiotypic Antibodies
Colorectal Neoplasms
Prostatic Neoplasms
Research Design
Clone Cells
Genotype
Monoclonal Antibodies

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Fehm, T., Sagalowsky, A. I., Clifford, E., Beitsch, P., Saboorian, H., Euhus, D., ... Uhr, J. (2002). Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clinical Cancer Research, 8(7), 2073-2084.

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. / Fehm, Tanja; Sagalowsky, Arthur I; Clifford, Edward; Beitsch, Peter; Saboorian, Hossein; Euhus, David; Meng, Songdong; Morrison, Larry; Tucker, Thomas; Lane, Nancy; Ghadimi, B. Michael; Heselmeyer-Haddad, Kerstin; Ried, Thomas; Rao, Chandra; Uhr, Jonathan.

In: Clinical Cancer Research, Vol. 8, No. 7, 2002, p. 2073-2084.

Research output: Contribution to journalArticle

Fehm, T, Sagalowsky, AI, Clifford, E, Beitsch, P, Saboorian, H, Euhus, D, Meng, S, Morrison, L, Tucker, T, Lane, N, Ghadimi, BM, Heselmeyer-Haddad, K, Ried, T, Rao, C & Uhr, J 2002, 'Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant', Clinical Cancer Research, vol. 8, no. 7, pp. 2073-2084.
Fehm, Tanja ; Sagalowsky, Arthur I ; Clifford, Edward ; Beitsch, Peter ; Saboorian, Hossein ; Euhus, David ; Meng, Songdong ; Morrison, Larry ; Tucker, Thomas ; Lane, Nancy ; Ghadimi, B. Michael ; Heselmeyer-Haddad, Kerstin ; Ried, Thomas ; Rao, Chandra ; Uhr, Jonathan. / Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. In: Clinical Cancer Research. 2002 ; Vol. 8, No. 7. pp. 2073-2084.
@article{4f97118c8ac8474aa3339e295e49e550,
title = "Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant",
abstract = "Purpose: Numerous studies of circulating epithelial cells (CECs) have been described in cancer patients, and genetic abnormalities have been well documented. However, with one exception in colorectal cancer, there has been no report of matching the genetic abnormalities in the CECs with the primary tumor. The purpose of this investigation was to determine (a) whether CECs in patients including those with early tumors are aneusomic and (b) whether their aneusomic patterns match those from the primary tumor, indicating common clonality. Experimental Design: Thirty-one cancer patients had CECs identified by immunofluorescence staining using a monoclonal anti-cytokeratin antibody. Their CECs were analyzed by enumerator DNA probes for chromosomes 1, 3, 4, 7, 8, 11, or 17 by dual or tricolor fluorescence in situ hybridization. Touch preparations of the primary tumor tissue were available from 17 of 31 patients and hybridized with the same set of probes used to genotype the CECs. Results: The number of CECs from each patient ranged from 1-92 cells/cytospin. CECs showed abnormal copy numbers for at least one of the probes in 25 of 31 patients. Touch preparations from the primary tumors of 13 patients with aneusomic CECs were available. The pattern of aneusomy matched a clone in the primary tumor in 10 patients. Conclusions: We conclude that the vast majority of CECs in breast, kidney, prostate, and colon cancer patients are aneusomic and derived from the primary tumor.",
author = "Tanja Fehm and Sagalowsky, {Arthur I} and Edward Clifford and Peter Beitsch and Hossein Saboorian and David Euhus and Songdong Meng and Larry Morrison and Thomas Tucker and Nancy Lane and Ghadimi, {B. Michael} and Kerstin Heselmeyer-Haddad and Thomas Ried and Chandra Rao and Jonathan Uhr",
year = "2002",
language = "English (US)",
volume = "8",
pages = "2073--2084",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant

AU - Fehm, Tanja

AU - Sagalowsky, Arthur I

AU - Clifford, Edward

AU - Beitsch, Peter

AU - Saboorian, Hossein

AU - Euhus, David

AU - Meng, Songdong

AU - Morrison, Larry

AU - Tucker, Thomas

AU - Lane, Nancy

AU - Ghadimi, B. Michael

AU - Heselmeyer-Haddad, Kerstin

AU - Ried, Thomas

AU - Rao, Chandra

AU - Uhr, Jonathan

PY - 2002

Y1 - 2002

N2 - Purpose: Numerous studies of circulating epithelial cells (CECs) have been described in cancer patients, and genetic abnormalities have been well documented. However, with one exception in colorectal cancer, there has been no report of matching the genetic abnormalities in the CECs with the primary tumor. The purpose of this investigation was to determine (a) whether CECs in patients including those with early tumors are aneusomic and (b) whether their aneusomic patterns match those from the primary tumor, indicating common clonality. Experimental Design: Thirty-one cancer patients had CECs identified by immunofluorescence staining using a monoclonal anti-cytokeratin antibody. Their CECs were analyzed by enumerator DNA probes for chromosomes 1, 3, 4, 7, 8, 11, or 17 by dual or tricolor fluorescence in situ hybridization. Touch preparations of the primary tumor tissue were available from 17 of 31 patients and hybridized with the same set of probes used to genotype the CECs. Results: The number of CECs from each patient ranged from 1-92 cells/cytospin. CECs showed abnormal copy numbers for at least one of the probes in 25 of 31 patients. Touch preparations from the primary tumors of 13 patients with aneusomic CECs were available. The pattern of aneusomy matched a clone in the primary tumor in 10 patients. Conclusions: We conclude that the vast majority of CECs in breast, kidney, prostate, and colon cancer patients are aneusomic and derived from the primary tumor.

AB - Purpose: Numerous studies of circulating epithelial cells (CECs) have been described in cancer patients, and genetic abnormalities have been well documented. However, with one exception in colorectal cancer, there has been no report of matching the genetic abnormalities in the CECs with the primary tumor. The purpose of this investigation was to determine (a) whether CECs in patients including those with early tumors are aneusomic and (b) whether their aneusomic patterns match those from the primary tumor, indicating common clonality. Experimental Design: Thirty-one cancer patients had CECs identified by immunofluorescence staining using a monoclonal anti-cytokeratin antibody. Their CECs were analyzed by enumerator DNA probes for chromosomes 1, 3, 4, 7, 8, 11, or 17 by dual or tricolor fluorescence in situ hybridization. Touch preparations of the primary tumor tissue were available from 17 of 31 patients and hybridized with the same set of probes used to genotype the CECs. Results: The number of CECs from each patient ranged from 1-92 cells/cytospin. CECs showed abnormal copy numbers for at least one of the probes in 25 of 31 patients. Touch preparations from the primary tumors of 13 patients with aneusomic CECs were available. The pattern of aneusomy matched a clone in the primary tumor in 10 patients. Conclusions: We conclude that the vast majority of CECs in breast, kidney, prostate, and colon cancer patients are aneusomic and derived from the primary tumor.

UR - http://www.scopus.com/inward/record.url?scp=0035992272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035992272&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 2073

EP - 2084

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 7

ER -